Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility

Small bowel accounts for only 0.5% of cancer cases in the US but incidence rates have been rising at 2.4% per year over the past decade. One-third of these are adenocarcinomas but little is known about their molecular pathology and no molecular markers are available for clinical use. Using a retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvi, Muhammad A., McArt, Darragh G., Kelly, Paul, Fuchs, Marc-Aurel, Alderdice, Matthew, McCabe, Clare M., Bingham, Victoria, McGready, Claire, Tripathi, Shailesh, Emmert-Streib, Frank, Loughrey, Maurice B., McQuaid, Stephen, Maxwell, Perry, Hamilton, Peter W., Turkington, Richard, James, Jacqueline A., Wilson, Richard H., Salto-Tellez, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper: Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673235/
https://www.ncbi.nlm.nih.gov/pubmed/26315110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673235/
https://www.ncbi.nlm.nih.gov/pubmed/26315110

Ejemplares similares